Pure Global

Roche immunoassay free thyroxine fourth generation assay - Taiwan Registration 9d5c6d90f7cbe37e8c9803f64bda23c8

Access comprehensive regulatory information for Roche immunoassay free thyroxine fourth generation assay in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 9d5c6d90f7cbe37e8c9803f64bda23c8 and manufactured by ROCHE DIAGNOSTICS GMBH. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
9d5c6d90f7cbe37e8c9803f64bda23c8
Registration Details
Taiwan FDA Registration: 9d5c6d90f7cbe37e8c9803f64bda23c8
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Roche immunoassay free thyroxine fourth generation assay
TW: ็พ…ๆฐๅ…็–ซๅˆ†ๆžๆธธ้›ข็”ฒ็‹€่…บ็ด ็ฌฌๅ››ไปฃๆชข้ฉ—่ฉฆๅŠ‘
Risk Class 2

Registration Details

9d5c6d90f7cbe37e8c9803f64bda23c8

DHA05603615402

Company Information

Germany

Product Details

Model 09043276190: This product uses electrochemiluminescence immunoassay (ECLIA) with cobas e 411, cobas e 601, cobas 602 analyzers to quantitatively detect free thyroxine in human serum and plasma in vitro. Model 09043284190: This product uses electrochemiluminescence immunoassay (ECLIA) with cobas 402 and cobas e 801 immunoassay analyzer to quantitatively detect free thyroxine in human serum and plasma in vitro. Model 09043292190: This product is used on the Cobas E Immunoassay Analyzer to correct the Elecsys FT4 IV Quantitative Reagent.

A Clinical chemistry and clinical toxicology

A.1695 ๆธธ้›ข็”ฒ็‹€่…บ็ด ่ฉฆ้ฉ—็ณป็ตฑ;; A.1150 ๆ กๆญฃๅ“

Input;; QMS/QSD

Dates and Status

Jan 31, 2023

Jan 31, 2028